mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |